Alexion Pharmaceuticals Inc. (ALXN) revealed earnings for fourth quarter that dropped from the same period last year.
The company's bottom line totaled $535.8 million, or $2.42 per share. This compares with $889.0 million, or $4.00 per share, in last year's fourth quarter.
Excluding items, Alexion Pharmaceuticals Inc. reported adjusted earnings of $664.5 million or $2.96 per share for the period.
Analysts had expected the company to earn $2.56 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 15.2% to $1.59 billion from $1.38 billion last year.
Alexion Pharmaceuticals Inc. earnings at a glance:
-Earnings (Q4): $664.5 Mln. vs. $611.0 Mln. last year.-EPS (Q4): $2.96 vs. $2.71 last year.-Analysts Estimate: $2.56 -Revenue (Q4): $1.59 Bln vs. $1.38 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.